Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid Tumors

Status Active, not recruiting

Clinical Trial Summary

This study is an open label prospective trial of TheraSphere treatment for patients who have liver metastases who have failed or are intolerant to other systemic or liver directed therapies. Patients will be treated with TheraSphere at doses of 120 ± 10% Gy, and then followed for time to progression (TTP), safety, and overall survival.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Liver Neoplasms

Clinical Trial Details

NCT number	NCT01177007
Study type	Interventional
Source	Sidney Kimmel Comprehensive Cancer Center
Contact
Status	Active, not recruiting
Phase	Phase 2
Start date	September 2010
Completion date	August 2014

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03651154` - Hypovolemic Phlebotomy to Reduce Blood Transfusions in Major Hepatic Resections	N/A
Not yet recruiting	`NCT03592550` - The eValuation of Image Guidance of Stereotactic Body Radiotherapy Using Ultrasound: Assessment in Liver
Not yet recruiting	`NCT02521129` - A New Track Ablation Device for Liver Biopsy: A Feasibility Study	Phase 1/Phase 2
Not yet recruiting	`NCT02168608` - Remote Ischemia Precondition (RIPC) for Hepatic Protection in Patients Undergoing Hepatectomy	N/A
Enrolling by invitation	`NCT01465425` - Extracolonic Findings on Computed Tomography (CT) Colonography
Completed	`NCT00788697` - SonoVue®-Enhanced Ultrasound Versus Unenhanced US for Focal Liver Lesion Characterization	Phase 3
Recruiting	`NCT01564810` - Cetuximab in Combination With Chemotherapy for the Treatment of Metastatic Colorectal Cancer	Phase 4
Completed	`NCT00094003` - Study of NS-9 in Patients With Liver Metastases	Phase 1
Terminated	`NCT00051532` - Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma	N/A
Completed	`NCT00001587` - A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) With Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the Liver	Phase 1
Completed	`NCT00222664` - Qidong Hepatitis B Intervention Study	Phase 4
Recruiting	`NCT04518852` - TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC	Phase 2
Completed	`NCT03289273` - Observational Study to Evaluate, Under Real-world Practice Conditions, the Safety and Effectiveness of Regorafenib in Patients Diagnosed With Unresectable Hepatocellular Carcinoma (uHCC)
Terminated	`NCT03349255` - Clinical Study of ET1402L1-CAR T Cells in AFP Expressing Hepatocellular Carcinoma	Phase 1
Recruiting	`NCT05068180` - Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients	Phase 4
Recruiting	`NCT03715517` - Spinal Anesthesia For Enhanced Recovery After Liver Surgery	N/A
Terminated	`NCT03685591` - PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors	Phase 1
Terminated	`NCT01744054` - Microsphere Localization Using PET/MRI or PET/CT in Patients Following Radioembolization	Phase 1
Active, not recruiting	`NCT02969096` - Clinical Study of Targeted Cryoablation Therapy in the Treatment of Hepatic Carcinoma	Phase 2
Recruiting	`NCT01214343` - Comparing Efficacy of Sorafenib Versus Sorafenib in Combination With Low-dose FP in Patients With Advanced HCC	Phase 3